No Data
The trend of risk aversion continues, reaching the 33,000 yen level for the first time in eight months.
The Nikkei Average continued to decline significantly. It closed at 33,780.58 yen, down 955.35 yen (estimated Volume 3.2 billion 10 million shares), breaking below 34,000 yen for the first time in about eight months since August 5 of last year. Due to the USA's mutual tariffs and concerns over a global economic slowdown, the major Overseas stock indices plummeted the previous day, leading to a steep decline in the Nikkei Average at the start. It fell below the 34,000 yen mark in the middle of the morning session. After that, there were some buybacks due to a rebound from the sharp declines.
The Nikkei average is down about 1,140 yen, with Advantest, SoftBank Group, and Tokyo Electron contributing negatively at the top.
As of 12:46 PM on the 4th, the Nikkei average stock price is trading around 33,600 yen, approximately 1,140 yen lower than the previous day. The afternoon session also started with a prevailing Sell. At 12:43 PM, it reached 33,472.82 yen, down 1,263.11 yen. The foreign exchange market shows 1 dollar equals approximately 145.70 yen, currently moving slightly towards a stronger yen. The contribution of the adopted stocks in the Nikkei average stock price has negatives from Advantest <6857.T>, SoftBank Group <9984.T>, and Tokyo Electron <8035.T> being at the top.
The Nikkei average is up by about 150 yen, and after the initial buying, the movement is heavy on the upside = April 1st morning session.
On April 1st at around 10:01 AM, the Nikkei average stock price is trading about 150 yen higher than the previous day, around 35,770 yen. At 9:24 AM, it reached 36,052.54 yen, up 434.98 yen. In the local market on March 31st, the Dow Inc rebounded for the first time in four days while the Nasdaq composite index fell slightly for the fourth consecutive day. However, Japanese stocks saw a rebound following yesterday's sharp decline and a pause in the trend of yen appreciation, leading to an initial buying surge. Still, after this initial buying, selling occurred as investors waited for a price recovery.
Welcome speech for the 2025 Terumo Group entrance ceremony (excerpt)
Top April 1, 2025, Terumo Corporation, Representative Director, President, CEO Mitsuaki Samejima. Today, 252 new members have joined the Terumo Group. A heartfelt welcome to everyone. Do you all have dreams? I have one. It is to make Terumo a true Global top league company. A top league company does not simply mean having large sales figures. It means earning the respect of stakeholders such as healthcare professionals and patients.
Terumo has established "Our Promise" as the direction that the entire group aims to pursue in the long term.
On April 1, 2025, Terumo Corporation (headquartered in Shibuya, Tokyo, President: Mitsuhiro Samejima) announced today the direction for long-term pursuit across the entire group to realize its corporate philosophy of "Contributing to society through health care" as "Our Promise." Terumo's Our Promise is "Unwavering commitment to patients."
Announcement of the name change of some businesses in the cardiovascular company and the change of the disclosure segment in the blood and cell Technology company (PDF 477.39 KB)
